GRDN Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
371.1M
+5.5%
351.8M
+4.5%
336.6M
-15.3%
397.6M
+5.3%
377.4M
Cost of Revenue
285.8M
+5.2%
271.7M
+4.4%
260.3M
-16.6%
312.1M
+3.1%
302.7M
Gross Profit
85.2M
+6.5%
80.0M
+4.9%
76.3M
-10.8%
85.5M
+14.4%
74.7M
Operating Expenses
60.2M
+1.3%
59.4M
+1.3%
58.6M
+7.1%
54.7M
-6.2%
58.4M
R&D
0
0
0
0
0
SG&A
60.2M
+1.3%
59.4M
+1.3%
58.6M
+7.1%
54.7M
-6.2%
58.4M
Operating Income
25.1M
+21.4%
20.6M
+16.8%
17.7M
-42.5%
30.8M
+88.1%
16.4M
EBITDA
31.0M
+17.2%
26.5M
+11.8%
23.7M
-35.2%
36.5M
+64.5%
22.2M
Net Income
19.1M
-13.6%
22.1M
+63.3%
13.5M
-36.3%
21.3M
+121.7%
9.6M
EPS (Basic)
$0.29
-17.1%
$0.35
+66.7%
$0.21
-36.4%
$0.33
+106.3%
$0.16
EPS (Diluted)
$0.29
-14.7%
$0.34
+61.9%
$0.21
-36.4%
$0.33
+120.0%
$0.15
Shares (Diluted)
63.9M
+0.1%
63.8M
+0.2%
63.7M
+0.1%
63.6M
+0.3%
63.4M
Guardian Pharmacy Services (GRDN) — Financials